chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suffers from a large number of chronic aches, pains and joint problem. The day after the booster she notice she had no aches and pains; chills; headache; standard feeling crappy; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (standard feeling crappy), THERAPEUTIC RESPONSE UNEXPECTED (suffers from a large number of chronic aches, pains and joint problem. The day after the booster she notice she had no aches and pains), CHILLS (chills) and HEADACHE (headache) in an 80-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 015H22A) for COVID-19 prophylaxis.     It was reported that patient had not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  The patient's past medical history included Coronary artery bypass (20 years ago). Concurrent medical conditions included Dust allergy, Allergic rhinitis (excl hay fever), Allergic reaction to bee sting, Cardiac discomfort (Heart problem), Blood pressure high, Allergy to antibiotic (erythromycin allergy), Penicillin allergy and Allergy (perfume allergy).    On 12-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Dec-2022, the patient experienced CHILLS (chills) and HEADACHE (headache). On an unknown date, the patient experienced FEELING ABNORMAL (standard feeling crappy) and THERAPEUTIC RESPONSE UNEXPECTED (suffers from a large number of chronic aches, pains and joint problem. The day after the booster she notice she had no aches and pains). At the time of the report, FEELING ABNORMAL (standard feeling crappy), CHILLS (chills) and HEADACHE (headache) had resolved and THERAPEUTIC RESPONSE UNEXPECTED (suffers from a large number of chronic aches, pains and joint problem. The day after the booster she notice she had no aches and pains) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment information provided.
FEVER; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced fever, and nausea. The action taken with covid-19 vaccine  was not applicable. The outcome of the fever and nausea was not reported. This report was non-serious.
2nd Moderna COVID Vaccine given 20 days after 1st. No adverse reaction noted.
Swelling, rash, itching, warm worsened for 3 days, then started to go away.  5th day, almost gone, still red and itches a bit, still swollen a bit.
Information has been received from an office manager concerning a female who on 09-NOV-2006 was vaccinated with a dose of Pneumovax 23.  Subsequently the patient developed redness and a swollen arm.  The patient's outcome was unknown.  Additional information has been requested.
Warm on injection site; swollen on injection site; Area is the size of a mosquito bite; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm on injection site), VACCINATION SITE SWELLING (swollen on injection site) and SWELLING (Area is the size of a mosquito bite) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm on injection site), VACCINATION SITE SWELLING (swollen on injection site) and SWELLING (Area is the size of a mosquito bite). At the time of the report, VACCINATION SITE WARMTH (Warm on injection site), VACCINATION SITE SWELLING (swollen on injection site) and SWELLING (Area is the size of a mosquito bite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
HYPERSOMNIA W SLEEP APNEA 4/21/2023 DIVERTICULITIS HYPERSOMNIA W SLEEP APNEA 4/21/2023 AORTIC VALVE STENOSIS
Dizziness; Pain in right wrist, Pins and needles right arm/hand, then left arm hand.  Now, pins and needles in feet and face.  Dizziness; Pins and needles right arm/hand, then left arm hand.  Now, pins and needles in feet and face.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on an unknown date in Feb2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included ibuprofen (ADVIL) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Mar2021 the patient experienced pain in right wrist, pins and needles right arm/hand, then left arm hand. Now, pins and needles in feet and face. Dizziness. Patient received treatment for the events which included antibiotic. The events resulted in doctor or other healthcare professional office/clinic visit. Clinical outcome of dizziness, wrist pain, pins and needles were not recovered. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 at 16:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: updated narrative.
08/18/02 @ 7:00 am awoke with rash all over and  swelling noted all over body. Went to ER @ 11:15 & received injection. He went again ER at night.
Patient had 2 vaccines given in left upper arm, according to patient it was TDap and pneumonia and the flu was given in the right arm, according to pharmacy the flu and pneumonia were given in left arm and tdap in the right.  The injections in the left arm were given very low in the left upper arm, not appropriate anatomic position for IM injections, the patient has redness, warmth, swelling, and ecchymosis noted to the top injection site.
This child was signed up by administrative staff for the FluMist which was not age appropriate. Vaccine was given to this 17 month old by an RN that was volunteering (MRC Volunteer) at our flu immunization clinic. Reported to our Medical Director. No adverse events noted. Attempting to notify the patients parent at this time. Will boost with Pediatric Fluzone.
Rash until now; body-flu symptoms (generalized musculoskeletal aching) extreme exhaustion for several days.
On 09/08/2022 I received my Covid-19 vaccine. 02/08/2023 I started experiencing muscle pain and burning throughout both legs. Symptoms lasted about a week.
Swollen lymph nodes; Fever 101; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 10May2021 at 09:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medication taken within two weeks of vaccination was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 08:45 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 12May2021 at 06:00, the patient experienced swollen lymph nodes and fever 101. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. On 12May2021, the patient recorded body temperature and the result was 101 (unit unspecified). The clinical outcome of the events swollen lymph nodes was not recovered and that of fever 101 was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
I am feeling injection pain; back pain; tiredness; joint pain; weakness; feel unwell; extreme migraine; chills; over heated; sweating; I was also experiencing pain in my left arm, left shoulder blade, and lower left back area; headache; This is a spontaneous report from a contactable Other Health Care Professional(Patient). A 22-years-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 25Feb2021 at 15:15 (Batch/Lot Number was unknown) as 1st dose, single dose for covid-19 immunisation. Medical history included Brain cyst which causes frequent migraines. Concomitant medications included Magnesium (MAGNESIUM) pills, Vitamin b complex (B-COMPLEX [VITAMIN B COMPLEX]) pills and Clariton pills taken as other medications in two weeks The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any Known allergies. On 25Feb2021 at 16:00, About 40min after the first dose patient experienced headache. In the evening about 4 hours after the dose she experienced some chills while she was also feeling over heated and sweating but with no fever ever taking place. During this time she was also experienced pain in her left arm, left shoulder blade, and lower left back area. In the morning at around 6am, about 15 hours after the dose, patient woke up with an extreme migraine as well as chills but still with no fever. Now, at around 2pm the following day about 23 hours after the first dose patient felt injection pain, back pain, tiredness, headache, chills, joint pain, and weakness. She had no fever still and all of the symptoms were minor feeling but still made her feel unwell when all combined together. No treatment was given for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Arm was sore, not too bad; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient received a shot and his/her arm was sore for a few days, but not too bad. The reporter worth that comparing to these horror stories, which he/she was reading on this thread. The follow-up could not be possible as no contact details were available. For tolerance of 2nd shot, refer case US2022AMR015226. The case was linked with case US2022AMR015237 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR015226:Same reporter. US-GLAXOSMITHKLINE-US2022AMR015237:Same reporter. Hearsay.
devel fever 103.5 mom called office instructed to given APAP & bath w/lukewarm water; cont w/APAP q 4-6 hrs as needed;
Itchy in the middle of the rash; Rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy in the middle of the rash) and VACCINATION SITE RASH (Rash around the injection site) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Itchy in the middle of the rash) and VACCINATION SITE RASH (Rash around the injection site). At the time of the report, RASH PRURITIC (Itchy in the middle of the rash) and VACCINATION SITE RASH (Rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient was not provided.  Treatment information was not provided.
This solicited report was received from a physician concerning a female patient of unknown age enrolled in a patient support program. The patient's concurrent conditions and medical history, as well as concomitant medications, were not provided. On 07-DEC-2016, the subject was vaccinated by an unspecified physician with ZOSTAVAX (lot# and expiration date were unknown) subcutaneously for shingles prevention (prophylaxis). On an unknown date, the patient experienced rash generalised. At the reporting time, the outcome of rash generalised was unknown. The causality between ZOSTAVAX and rash generalised was not assessed. The reporter stated that the event was not life threatening. Additional information has been requested.
pt  said her arm hurt and could not pick up/move  her  right arm , she went to ER(10/19/2020) and the provider there said a nerve was hit when the shot was given.  he prescribed her a medrol dose pack
Next day after patient got vaccine her upper portion of arm was red and hot. It went down after two days, however today on the 10th (8 days after vaccine) it became red and hot again. Patient feels very slight pain.
pain only at the time of administration where he felt like the healhcare provider hit a nerve; pain only at the time of administration where he felt like the healhcare provider hit a nerve; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (pain only at the time of administration where he felt like the healhcare provider hit a nerve) and VACCINATION SITE PAIN (pain only at the time of administration where he felt like the healhcare provider hit a nerve) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (SUBOXONE) for an unknown indication.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced NEURALGIA (pain only at the time of administration where he felt like the healhcare provider hit a nerve) and VACCINATION SITE PAIN (pain only at the time of administration where he felt like the healhcare provider hit a nerve). At the time of the report, NEURALGIA (pain only at the time of administration where he felt like the healhcare provider hit a nerve) and VACCINATION SITE PAIN (pain only at the time of administration where he felt like the healhcare provider hit a nerve) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient received 2nd dose on 15 May 2021.  No medical history was provided by the reporter. No treatment information was provided.
Flare-up of autoimmune pain, most dramatically from fibromyalgia trigger points; existing fibromyalgia points in both shoulder blades became extremely painful, radiating across my entire back, including my cervical spine, where I also have arthritis; pronounced muscle weakness in arms and legs, as well as widespread myalgia, and profound malaise and fatigue; difficulty in walking -- gait was shuffling and unsteady, resulting in one major fall, but without serious injury; difficulty in getting out of bed or rising from chairs or in/out of vehicles; inflammation of lymphatic system, including inflamed nodes in both armpits and breasts; sporadic flare-up of lymph nodes continue through May 2022; extreme fatigue for more than 12 weeks; muscle weakness and fatigue is lingering, as of the filing of this report in May 2022.  Both existing PAC and PVC cardiac arrhythmias increased, but apparently left no additional damage.  Increased symptoms of Sjogren's, extremely dry eyes and resultant diminished visual acuity; cannot currently see well enough to drive safely at night, with difficulty seeing street signs in daytime; prescription eye drops are not helping much.  As of May 2022, my vision has diminished to 20/30 and 20/40.  I now must wear glasses to drive during daylight and at night.
Raised, red, itchy, hot area, on left deltoid beginning 03/01/2006, but resolving now to scattered redness, flat warm itching and pain.  No treatment.
Dry mouth, tachycardia, weakness, lightheaded. Cleared by medics.
syncope; This case was reported by a nurse via sales rep and described the occurrence of syncope in a patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced syncope (serious criteria GSK medically significant). On an unknown date, the outcome of the syncope was unknown.   It was unknown if the reporter considered the syncope to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced syncope following a dose of Bexsero. Consent to follow up was denied.
This spontaneous report as received from the patient's wife via an online experience survey and refers to a male patient of unknown age. The patient's pertinent medical history or drug allergies/drug reactions were not reported. On an unknown date the patient, (reported as "on Friday", the patient was vaccinated with PNEUMOVAX 23 (lot number, expiration date, dose, strength, route of administration and anatomical route were not reported). There was no concomitant medication reported. On an unknown date, almost immediately after the vaccination, the patient started to feel ill and experienced myalgia, nausea, chills, pyrexia of almost 103 degrees. The reporter stated that the patient was sick the entire weekend (date was not provided) until his fever broke on Sunday night (date was not specified). Additionally, the reporter stated that "he (the patient), spent the entire time in bed and missed a 50th birthday party and visiting relatives". At the reporting time, the outcome of myalgia, nausea, chills and malaise was unknown. The outcome of pyrexia was reported as recovered on an unspecified date. Additional information is not expected as no reporter details were provided.
pt recvd vax; devel a sterile abscess at inject site; tx w/ incision & drainage of the abscess in sep93;also ATB adm;
Jansen Covid-19 vaccine EUA Muscle ache  Naseua and Vomiting Flu like symptoms
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 47-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Sore arm immediately after the vaccine. I was maybe tired and achy. No big deal. I moved my arm up and down a lot. This recent numbness and tingling intermittently all through my body. They could have been stroke symptoms, even though I have no stroke indicator risk. I went to ER because they lasted so long. I still have numbness that runs through all my body. I'll touch my chest and it feels normal, and five minutes later it's numb; that happens on feet as well. It comes and goes randomly, completely randomly. It is uncomfortable but have full strength and full range of motion and balance. Lips feel swollen, they started out tingly when I went to ER but now it's not tingly in lips but they feel swollen yet they don't look swollen. And that swollen feeling comes and goes, as well. Neurologist said that the best guess was virus and it was irritating the nerves. I do still have the symptoms.
Diagnosed with LUPUS - inflamed heart, hair loss, Breast Tumor,  and various other issues
No additional AEs; Caller reported expired dose of MMR II was administered; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported.   On 24-MAR-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # U006488, expiration date: 26-FEB-2023 (dose, rout of administration, anatomical location not provided) as prophylaxis. The vaccine was reconstituted with sterile diluent (lot # W014210, expiration date: 27-NOV-2024). No additional adverse events were reported.
back problem; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 06Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK DISORDER (non-serious), outcome "unknown", described as "back problem".  Additional information: Patient has a back problem and he wanted to ask if he can take the tablet or the medicine before taking the second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore arm but with increasing headache over night, then weakness and nausea. in the morning.  This caused me to faint when I got up from bed for a Tylenol at 5:00 am.